Open-Label Evaluation of Venlafaxine Sustained Release in Outpatients with Generalized Anxiety Disorder with Comorbid Major Depression or Dysthymia: Effectiveness, Tolerability and Predictors of Response

Publisher： Karger

E-ISSN： 1423-0224|46|3|145-149

ISSN： 0302-282x

Source： Neuropsychobiology, Vol.46, Iss.3, 2002-11, pp. : 145-149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Confirmation of the Neurophysiologically Predicted Therapeutic Effects of Trazodone on Its Target Symptoms Depression, Anxiety and Insomnia by Postmarketing Clinical Studies with a Controlled-Release Formulation in Depressed Outpatients

By  

Neuropsychobiology, Vol. 48, Iss. 4, 2003-12 ,pp. : 194-208

Karger

Access to resources Recommend Favorite

Influence of BDNF Variants on Diagnosis and Response to Treatment in Patients with Major Depression, Bipolar Disorder and Schizophrenia

By  

Neuropsychobiology, Vol. 65, Iss. 1, 2011-11 ,pp. : 1-11

Karger

Access to resources Recommend Favorite

A Randomised Study Comparing Escitalopram with Venlafaxine XR in Primary Care Patients with Major Depressive Disorder

By  

Neuropsychobiology, Vol. 50, Iss. 1, 2004-06 ,pp. : 57-64

Karger

Access to resources Recommend Favorite

Appearance of Frontal Midline Theta Activity in Patients with Generalized Anxiety Disorder

By  

Neuropsychobiology, Vol. 41, Iss. 2, 2000-01 ,pp. : 108-112

Karger

Access to resources Recommend Favorite

A Pilot Study of Anterior Cingulate Cortex Neurochemistry in Adolescents with Generalized Anxiety Disorder

By  

Neuropsychobiology, Vol. 67, Iss. 4, 2013-04 ,pp. : 224-229

Karger

Access to resources Recommend Favorite